Dr Nick Medland is a clinical epidemiologist researching the tracking the community impact of clinical interventions on infectious diseases transmission, including HIV and sexually transmitted infection. He is a consultant physician in HIV and sexual health. He is the recipient of an Australian Government NHMRC early career research fellowship with the Surveillance, Evaluation and Research Program at the Kirby Institute for infection and immunity in society, Faculty of Medicine, UNSW. His research focusses on the population effects of biological HIV prevention (pre-exposure prophylaxis and treatment-as-prevention) and clinical, diagnostic and surveillance initiatives to reduce the impact of HIV and STIs on vulnerable populations. He is president-elect of the Australasian Society of HIV, Viral Hepatitis and Sexual Health Medicine, the co-chair of the Australasian Sexual Health Alliance and an executive committee member of the Chapter of Sexual Health Medicine of the Royal Australasian College of Physicians. He has worked extensively in HIV programs in Vietnam.
Senior Research Fellow
Dr Nicholas Medland
MBBS Qld (1st)
BA Hons UCL (1st)
PhD Monash
FAChSHM
Publications
Journal articles
Medland N; Guy R, 2024, 'Who benefits from frequent asymptomatic STI screening?', The Lancet HIV, 11, pp. e201 - e202, http://dx.doi.org/10.1016/S2352-3018(24)00037-7
2024
Cornelisse VJ; Riley B; Medland NA, 2024, 'Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.52258
2024
Ung M; Martin S; Terris-Prestholt F; Quaife M; Tieosapjaroen W; Phillips T; Lee D; Chow EPF; Medland N; Bavinton BR; Pan SW; Mao L; Ong JJ, 2023, 'Preferences for HIV prevention strategies among newly arrived Asian-born men who have sex with men living in Australia: A discrete choice experiment', Frontiers in Public Health, 11, pp. 1018983, http://dx.doi.org/10.3389/fpubh.2023.1018983
2023
Abraham E; Chow EPF; Fairley CK; Lee D; Kong FYS; Mao L; Goller JL; Medland N; Bavinton BR; Sudarto B; Joksic S; Wong J; Phillips TR; Ong JJ, 2023, 'eSexualHealth: Preferences to use technology to promote sexual health among men who have sex with men and trans and gender diverse people', Frontiers in Public Health, 10, pp. 1064408, http://dx.doi.org/10.3389/fpubh.2022.1064408
2023
Cornelisse VJ; Ong JJ; Ryder N; Ooi C; Wong A; Kenchington P; Giola M; Donovan B; Dean JA; Molina JM; Medland NA, 2023, 'Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)', Sexual Health, 20, pp. 99 - 104, http://dx.doi.org/10.1071/SH23011
2023
de Oliveira Costa J; Lau S; Medland N; Gibbons S; Schaffer AL; Pearson SA, 2023, 'Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia', British Journal of Clinical Pharmacology, 89, pp. 1541 - 1553, http://dx.doi.org/10.1111/bcp.15614
2023
Ong JJ; Bourne C; Dean JA; Ryder N; Cornelisse VJ; Murray S; Kenchington P; Moten A; Gibbs C; Maunsell S; Davis T; Michaels J; Medland NA, 2023, 'Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update', Sexual health, 20, pp. 1 - 8, http://dx.doi.org/10.1071/SH22134
2023
Medland NA; Fraser D; Bavinton BR; Jin F; Grulich AE; Paynter H; Guy R; McManus H, 2023, 'Discontinuation of government subsidized HIV pre-exposure prophylaxis in Australia: a whole-of-population analysis of dispensing records', Journal of the International AIDS Society, 26, http://dx.doi.org/10.1002/jia2.26056
2023
Gray RT; Camara H; Khawar L; Grulich A; Guy R; McGregor S; Medland N, 2023, 'The application of new metrics for understanding trends in undiagnosed HIV among key populations', AIDS, 37, pp. 1851 - 1859, http://dx.doi.org/10.1097/QAD.0000000000003630
2023
Zhang Y; Holt M; Chan C; Applegate TL; Bavinton BR; Broady TR; Keen P; Wulandari LPL; Mao L; McManus H; Medland NA; Prestage G; Wiseman V; Guy RJ, 2023, 'National Surveillance of Home-Based HIV Testing Among Australian Gay and Bisexual Men, 2018–2020: Uptake After Commercial Availability of HIV Self-Tests', AIDS and Behavior, 27, pp. 4106 - 4113, http://dx.doi.org/10.1007/s10461-023-04124-x
2023
Cornelisse VJ; Heath-Paynter D; Delpech V; Read P; Apostolellis A; Medland NA; MacIntyre CR; Giola M; Kidd M, 2023, 'How Australia and Aotearoa New Zealand avoided large-scale mpox (formerly monkeypox) outbreaks in 2022–2023', Internal Medicine Journal, 53, pp. 1732 - 1738, http://dx.doi.org/10.1111/imj.16236
2023
Kohli M; Medland N; Fifer H; Saunders J, 2022, 'BASHH updated position statement on doxycycline as prophylaxis for sexually transmitted infections', Sexually Transmitted Infections, 98, pp. 235 - 236, http://dx.doi.org/10.1136/sextrans-2022-055425
2022
Wells N; Philpot SP; Murphy D; Ellard J; Howard C; Rule J; Fairley C; Prestage G; Brown G; Jin J; Kaldor J; Guy R; Grulich A; Mao L; Donovan B; Persson A; Medland N; Clifton B; Hilton P; Hammoud M; Malhotra S; Bastian L, 2022, 'Belonging, social connection and non-clinical care: Experiences of HIV peer support among recently diagnosed people living with HIV in Australia', Health and Social Care in the Community, 30, pp. e4793 - e4801, http://dx.doi.org/10.1111/hsc.13886
2022
Wells N; Prestage G; Murphy D; Medland N; Mao L; Howard C; Fairley C; Brown G; Philpot SP, 2022, 'Patient-centred approaches to providing care at HIV diagnosis: perspectives from healthcare and peer-support workers', Sexual Health, 19, pp. 448 - 455, http://dx.doi.org/10.1071/sh22052
2022
Medland NA; Zhang Y; Gunaratnam P; Lewis DA; Donovan B; Whiley DM; Guy RJ; Kaldor JM, 2022, 'Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: a global, systematic review, 1 January 2012 to 27 September 2020', Eurosurveillance, 27, http://dx.doi.org/10.2807/1560-7917.ES.2022.27.18.2100917
2022
Phillips TR; Medland N; Chow EPF; Maddaford K; Wigan R; Fairley CK; Bilardi JE; Ong JJ, 2022, 'Newly arrived Asian-born gay men in Australia: exploring men’s HIV knowledge, attitudes, prevention strategies and facilitators toward safer sexual practices', BMC Infectious Diseases, 22, http://dx.doi.org/10.1186/s12879-022-07174-z
2022
Sudarto B; Chow EPF; Medland N; Fairley CK; Wright EJ; Armishaw J; Price B; Phillips TR; Ong JJ, 2022, '“How PrEPared are you?”: Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in Australia', Frontiers in Public Health, 10, http://dx.doi.org/10.3389/fpubh.2022.946771
2022
Chidwick K; Pollack A; Busingye D; Norman S; Grulich A; Bavinton B; Guy R; Medland N, 2022, 'Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study', Sexual Health, 19, pp. 101 - 111, http://dx.doi.org/10.1071/SH21207
2022
Bhatt S; Bryant M; Lau H; Tee BK; Eu B; O’Bryan J; Woolley I; Mitchell J; Street A; Dobinson S; Medland N; Lamb J; Mahony A; Tramontana A; Lim LL; Wade A; Roder C; Mitchell W; Sherman C; Bramwell F; Aboltins C; Wong SH; Giourouki M; Hoy JF; McMahon JH, 2022, 'Successful expanded clinic network collaboration and patient tracing for retention in HIV care', AIDS Research and Therapy, 19, http://dx.doi.org/10.1186/s12981-022-00476-x
2022
Medland NA; Taylor R; Saunders J; Rayment M; Fox A; Sullivan A, 2022, 'Why sexual health clinics are important in the 2020s', Sexual Health, 19, pp. 329 - 335, http://dx.doi.org/10.1071/sh22078
2022
Doyle JS; Van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME, 2021, 'Microelimination of Hepatitis C among People with Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial', Clinical Infectious Diseases, 73, pp. E2164 - E2172, http://dx.doi.org/10.1093/cid/ciaa1500
2021
Bao Y; Medland NA; Fairley CK; Wu J; Shang X; Chow EPF; Xu X; Ge Z; Zhuang X; Zhang L, 2021, 'Predicting the diagnosis of HIV and sexually transmitted infections among men who have sex with men using machine learning approaches', Journal of Infection, 82, pp. 48 - 59, http://dx.doi.org/10.1016/j.jinf.2020.11.007
2021
Matthews G, 2021, 'Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial', Clinical Infectious Diseases, http://dx.doi.org/10.1093/cid/ciaa1500
2021
Van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS, 2020, 'The Impact of Markers of HIV Infection on Change in Liver Stiffness in People with HIV and Hepatitis C Virus Co-infection after Treatment and Cure of Hepatitis C', Journal of Acquired Immune Deficiency Syndromes, 85, pp. E81 - E89, http://dx.doi.org/10.1097/QAI.0000000000002487
2020
Medland NA; Grulich AE, 2020, 'Hiv diagnoses in australia fall as clinicians embrace pre-exposure prophylaxis', Australian Prescriber, 43, pp. 182 - 183, http://dx.doi.org/10.18773/austprescr.2020.048
2020
Su S; Fairley CK; Mao L; Medland N; Shen M; Li Y; Zhuang G; Zhang L, 2020, 'Estimation of the impact of changing drug-use trend on HIV, hepatitis C and syphilis epidemics among people who use synthetic drug-only, polydrug and heroin-only during 2005-2035 in China: Modelling study', Sexually Transmitted Infections, 96, pp. 608 - 614, http://dx.doi.org/10.1136/sextrans-2019-054360
2020
De Oliveira Costa J; Schaffer AL; Medland NA; Litchfield M; Narayan SW; Guy R; McManus H; Pearson SA, 2020, 'Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study', AIDS Patient Care and STDs, 34, pp. 81 - 91, http://dx.doi.org/10.1089/apc.2019.0278
2020
Medland N, 2020, 'Genomics against gonorrhoea', eLife, 9, pp. 1 - 3, http://dx.doi.org/10.7554/eLife.59379
2020
Medland NA; Banys P; Baton VP; Nadela J; Maher L; Tac-An I, 2020, 'Responding to expanding HIV epidemics in Cebu, Philippines', The Lancet HIV, 7, pp. e380 - e381, http://dx.doi.org/10.1016/S2352-3018(19)30405-9
2020
Phillips TR; Medland N; Chow EPF; Maddaford K; Wigan R; Fairley CK; Ong JJ; Bilardi JE, 2020, '“Moving from one environment to another, it doesn’t automatically change everything”. Exploring the transnational experience of Asian-born gay and bisexual men who have sex with men newly arrived in Australia', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0242788
2020
Su S; Fairley CK; Mao L; Medland NA; Jing J; Cheng F; Zhang L, 2019, 'Estimates of the national trend of drugs use during 2000–2030 in China: A population-based mathematical model', Addictive Behaviors, 93, pp. 65 - 71, http://dx.doi.org/10.1016/j.addbeh.2019.01.022
2019
Blackshaw LCD; Chow EPF; Varma R; Healey L; Templeton DJ; Basu A; Turner D; Medland NA; Rix S; Fairley CK; Chen MY, 2019, 'Characteristics of recently arrived Asian men who have sex with men diagnosed with HIV through sexual health services in Melbourne and Sydney', Australian and New Zealand Journal of Public Health, 43, pp. 424 - 428, http://dx.doi.org/10.1111/1753-6405.12926
2019
Gunaratnam P; Heywood AE; McGregor S; Jamil MS; McManus H; Mao L; Lobo R; Brown G; Hellard M; Marukutira T; Bretaña NA; Lang C; Medland N; Bavinton B; Grulich A; Guy R; Bretana N, 2019, 'HIV diagnoses in migrant populations in Australia—A changing epidemiology', PLoS ONE, 14, pp. e0212268, http://dx.doi.org/10.1371/journal.pone.0212268
2019
McManus H; Callander D; Donovan B; Russell DB; O'Connor CC; Davies SC; Lewis DA; Hellard ME; Chen MY; Petoumenos K; Varma R; Cogle A; Boyd MA; Grulich A; Pollard J; Medland N; Fairley CK; Guy RJ, 2019, 'Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015', Medical Journal of Australia, 210, pp. 269 - 275, http://dx.doi.org/10.5694/mja2.50006
2019
Santen DV; Hoy J; Agius P; Iser D; O'reilly M; Sasadeusz J; Stoove M; Roney J; Moore R; Bk T; Medland N; Fairley C; Gane E; Matthews G; Prins M; Hellard M; Doyle J, 2019, 'THU-098-Changes in liver stiffness measurements following DAA treatment among HIV/HCV-coinfected individuals: Does HIV contribute to liver disease after HCV cure?', Journal of Hepatology, 70, pp. e204 - e204, http://dx.doi.org/10.1016/s0618-8278(19)30379-2
2019
Medland NA; Chibo D; Chow EPF; Guy RJ; Fairley CK, 2019, 'Is differential access to prevention distorting HIV epidemiology in Australia?', The Lancet HIV, 6, pp. e492, http://dx.doi.org/10.1016/S2352-3018(19)30225-5
2019
Zhang L; Zou X; Xu Y; Medland N; Deng L; Liu Y; Su S; Ling L, 2019, 'The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden', Frontiers in Public Health, 7, pp. 327, http://dx.doi.org/10.3389/fpubh.2019.00327
2019
Jamil MS; McManus H; Callander D; Prestage G; Ali H; O’Connor CC; Chen M; McNulty AM; Knight V; Duck T; Keen P; Gray J; Medland N; Hellard M; Lewis DA; Grulich AE; Kaldor JM; Fairley CK; Donovan B; Guy RJ; Marshall L; Wilson D; Dickson B; Kong M; Smith LW; Cooper D; Selvey C; Holden J; Crooks L; Cooper C; Price K; de Wit J; Kelleher A; Mitchell J; Schmidt HM; Telfer B; Whittaker B; Cooper D; O'Connor C, 2018, 'Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics', AIDS and Behavior, 22, pp. 513 - 521, http://dx.doi.org/10.1007/s10461-017-2012-2
2018
Read TRH; Walker S; Chow EPF; Ong JJ; Bradshaw CS; Medland NA; Wigan R; Chen MY; Fairley CK, 2018, 'HIV testing with and without a clinical consultation among men who have sex with men: A randomized controlled trial', Journal of Acquired Immune Deficiency Syndromes, 78, pp. 406 - 412, http://dx.doi.org/10.1097/QAI.0000000000001688
2018
Chow EPF; Medland NA; Denham I; Wright EJ; Fairley CK, 2018, 'Decline in new HIV diagnoses among MSM in Melbourne', The Lancet HIV, 5, pp. e479 - e481, http://dx.doi.org/10.1016/S2352-3018(18)30217-0
2018
Medland NA; Chow EPF; Read THR; Ong JJ; Chen M; Denham I; Gunaratnum P; Fairley CK, 2018, 'Incident HIV infection has fallen rapidly in men who have sex with men in Melbourne, Australia (2013-2017) but not in the newly-arrived Asian-born', BMC Infectious Diseases, 18, pp. 410, http://dx.doi.org/10.1186/s12879-018-3325-0
2018
Medland NA; Chow EPF; Walker RG; Chen M; Read TRH; Fairley CK, 2018, 'Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate', International Journal of STD and AIDS, 29, pp. 227 - 236, http://dx.doi.org/10.1177/0956462417722133
2018
Gunaratnam P; McManus H; Watchirs-Smith L; McGregor S; Callander D; Brown G; Lobo R; O'Connor C; Hellard M; Medland N; Lewis D; Palmer C; Law M; Gray R; Donovan B; Guy R; Han A, 2018, 'People Born in Non-Main English Speaking Countries Are Less Likely to Start HIV Treatment Early in Australia: A National Cohort Analysis, 2014-15', Journal of Acquired Immune Deficiency Syndromes, 77, pp. E31 - E34, http://dx.doi.org/10.1097/qai.0000000000001585
2018
Doyle JS; Bowring AL; Cutts J; Roney J; Iser DM; Sasadeusz J; O’Reilly M; Fairley C; Gane E; Hoy J; Matthews GV; Medland N; Moore R; Prins M; Stoové M; Tee BK; Hellard ME, 2017, 'O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective', Journal of Virus Eradication, 3, pp. 2 - 2, http://dx.doi.org/10.1016/s2055-6640(20)30888-8
2017
Medland NA; Chow EPF; Bradshaw CS; Read THR; Sasadeusz JJ; Fairley CK, 2017, 'Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men', BMC Infectious Diseases, 17, pp. 185, http://dx.doi.org/10.1186/s12879-017-2288-x
2017
Medland NA; Nicholson S; Chow EPF; Read TRH; Bradshaw CS; Denham I; Fairley CK, 2017, 'Time from HIV infection to virological suppression: Dramatic fall from 2007 to 2016', AIDS, 31, pp. 2377 - 2385, http://dx.doi.org/10.1097/QAD.0000000000001634
2017
Medland NA; Chow EPF; McMahon JH; Elliott JH; Hoy JF; Fairley CK, 2017, 'Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015', PLoS ONE, 12, pp. e0177634, http://dx.doi.org/10.1371/journal.pone.0177634
2017
Medland NA; Mao L; Crooks L; de Wit J, 2016, 'Obstacles to prescribers' initiation early antiretroviral therapy: a barrier to achieving 90-90-90 goals', The Lancet HIV, 3, pp. e559 - e560, http://dx.doi.org/10.1016/S2352-3018(16)30172-2
2016
Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR, 2016, 'Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV', Osteoporosis International, 27, pp. 1737 - 1745, http://dx.doi.org/10.1007/s00198-015-3432-3
2016
Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Kamara DA; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J; Finlayson R; Cooper D; Carr A; Bloch M; Harrod M; Pett S; Petoumenos K; Gold J; Medland N; Sullivan J; Han A, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, 12, pp. e1001809, http://dx.doi.org/10.1371/journal.pmed.1001809
2015
McMahon JH; Moore R; Eu B; Tee BK; Chen M; El-Hayek C; Street A; Woolley I; Buggie A; Collins D; Medland N; Hoy J, 2015, 'Clinic network collaboration and patient tracing to maximize retention in HIV care', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0127726
2015
Medland NA; McMahon JH; Chow EPF; Elliott JH; Hoy JF; Fairley CK, 2015, 'The HIV care cascade: A systematic review of data sources, methodology and comparability', Journal of the International AIDS Society, 18, http://dx.doi.org/10.7448/IAS.18.1.20634
2015
Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD, 2014, 'Factors associated with D-dimer levels in HIV-infected individuals', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0090978
2014
Nordell AD; McKenna M; Borges AH; Duprez D; Neuhaus J; Neaton JD, 2014, 'Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation', JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3, http://dx.doi.org/10.1161/JAHA.114.000844
2014
Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A; Post J; Medland N; Boyd M, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e94858, http://dx.doi.org/10.1371/journal.pone.0094858
2014
McMahon JH; Medland N, 2014, '90-90-90: How do we get there?', The Lancet HIV, 1, pp. e10 - e11, http://dx.doi.org/10.1016/S2352-3018(14)70017-7
2014
Nguyen DB; Do NT; Shiraishi RW; Le YN; Tran QH; Huu Nguyen H; Medland N; Nguyen LT; Struminger BB, 2013, 'Outcomes of Antiretroviral Therapy in Vietnam: Results from a National Evaluation', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0055750
2013
Zetterberg E; Neuhaus J; Baker JV; Somboonwit C; Llibre JM; Palfreeman A; Chini M; Lundgren JD, 2013, 'Platelet count kinetics following interruption of antiretroviral treatment', AIDS, 27, pp. 59 - 68, http://dx.doi.org/10.1097/QAD.0b013e32835a104d
2013
Bjerk SM; Baker J; Emery S; Neuhaus JA; Angus BJ; Gordin F; Pett SL; Stephan C; Kunisaki KM, 2013, 'Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study', PLoS ONE, 8, pp. e56249, http://dx.doi.org/10.1371/journal.pone.0056249
2013
Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377
2012
Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, 26, pp. 2337 - 2344, http://dx.doi.org/10.1097/QAD.0b013e32835ab213
2012
Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miro J; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S, 2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, 12, pp. 219 - 227, http://dx.doi.org/10.1111/j.1468-1293.2010.00875.x
2011
Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, 6, pp. Article number e26885, http://dx.doi.org/10.1371/journal.pone.0026885
2011
Martinez E; Visnegarwala F; Grund B; Thomas A; Gibert C; Shlay J; Drummond F; Pearce D; Edwards S; Reiss P; El-Sadr W; Carr AD, 2010, 'The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters', AIDS, 24, pp. 353 - 363
2010
Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, 24, pp. 2657 - 2663
2010
Grund B; Peng G; Gibert C; Hoy JF; Isaksson R; Shlay J; Martinez E; Reiss P; Visnegarwala F; Carr AD, 2009, 'Continuous antiretroviral therapy decreases bone mineral density', AIDS, 23, pp. 1519 - 1529
2009
Rodger A; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis ; Goetz M; Phillips AN, 2009, 'Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection', Journal of Infectious Diseases, 200, pp. 973 - 983, http://dx.doi.org/10.1086/605447
2009
Abrams A; Levy Y; Losso MH; Babiker AG; Collins G; Cooper DA; Darbyshire JH; Emery S; Fox L; Gordin F; Lane HC; Lundgren JD; Mitsuyasu R; Neaton J; Phillips AN; Routy J; Tambussi G; Wentworth D, 2009, 'Interleukin-2 therapy in patients with HIV infection.', New England Journal of Medicine, 361, pp. 1548 - 1559
2009
Mocroft A; Wyatt C; Szczech L; Neuhaus J; El-Sadr W; Tracy R; Kuller L; Shlipak M; Angus B; Klinker H; Ross M, 2009, 'Interruption of antiretroviral therapy is associated with increased plasma cystatin C', AIDS, 23, pp. 71 - 82, http://dx.doi.org/10.1097/QAD.0b013e32831cc129
2009
El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, 149, pp. 289 - W62
2008
Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, 197, pp. 1133 - 1144, http://dx.doi.org/10.1086/586713
2008
Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, 197, pp. 1145 - 1155, http://dx.doi.org/10.1086/529523
2008
Allen K; Guy R; Leslie D; Goller J; Medland N; Roth N; Lewis J; Hellard M, 2008, 'The rise of infectious syphilis in Victoria and the impact of enhanced clinical testing', Australian and New Zealand Journal of Public Health, 32, pp. 38 - 42, http://dx.doi.org/10.1111/j.1753-6405.2008.00164.x
2008
Fox Z; Phillips AN; Cohen C; Neuhaus J; Baxter J; Emery S; Hirschel B; Hullsiek K; Stephan C; Lundgren JD, 2008, 'Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen', AIDS, 22, pp. 2279 - 2289
2008
Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, 198, pp. 1794 - 1803
2008
Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J; Abdurahman I; Ajam A; Alexander R; Aung A; Barry S; Becker B; Belbin M; Bishop C; Bisshop F; Bourne C; Brett T; Brown K; Butler A; Carmody C; Chan D; Chuah J; Conway D; Daly C; Davies S; Davis C; Davis B; Dever N; Donovan B; Eisen D; Eliades C; Elisha B; Fairley C; Feiglin A; Freeman A; Furner V; Garland S; Genn W; Giannakopoulos J; Glass F; Gold J; Goswami J; Gowers A; Grech J; Hackney P; Hanson B; Hartnell K; Harvey C; Hasan M; Hawkins S; Heley S; Herbst D; Hespe C; Irlicht M; Isaacs A; Katahanas L; Kelly M; Komarowski P; Kostic G; Kozminsky M; Lagios K; Lee D; Lewis P; Liang T; Lyttle H; Mackellar-Michelmore H; Macleod H; Marsh L; Marshall L; McCloskey J; McCurdy D; McEvoy P; McFarlane R; McKeegan P; McMurchie M; McNamee K; Medland N; Menon A; Meyerowitz C; Michaels W; Mobbs M; Montague A; Nicola N; Nurcombe C; O'Connor C; Ooi C; Ostrowskyl O; O'Sullivan M; Owen L; Papp K; Patten J; Panopoulous D; Pell C; Philpot R; Quan D; Quin J; Rhodes D, 2008, '2-Day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study (Sexual Health (2008) 5, 3, (219-225))', Sexual Health, 5, pp. 379, http://dx.doi.org/10.1071/SH08013_CO
2008
Bodsworth NJ; Bloch MT; Mcnulty A; Denham I; Doong N; Trottier S; Adena MA; Bonney M; Agnew J; Australo-Canadian Fast A, 2008, '2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study', Sexual Health, 5, pp. 219 - 225
2008
Guy R; Lim MSC; Wang YHJ; Medland N; Anderson J; Roth N; Hellard ME, 2007, 'A new surveillance system for monitoring HIV infection in Victoria, Australia', Sexual Health, 4, pp. 195 - 199, http://dx.doi.org/10.1071/SH07011
2007
Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, 8, pp. 112 - 123, http://dx.doi.org/10.1111/j.1468-1293.2007.00440.x
2007
Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85
2006
Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163
2005
Fairley CK; Hocking JS; Medland N, 2005, 'Syphilis: Back on the rise, but not unstoppable', Medical Journal of Australia, 183, pp. 172 - 173, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06985.x
2005
Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6
2004
Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249
2003
Lister NA; Smith A; Tabrizi S; Hayes P; Medland NA; Garland S; Fairley CK, 2003, 'Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in Men Who Have Sex with Men at Male-only Saunas', Sexually Transmitted Diseases, 30, pp. 886 - 889, http://dx.doi.org/10.1097/01.OLQ.0000099160.26205.22
2003
Baker D; Law MG; Petoumenos K; Smith DE; Anderson JA; Roth N; Mallal SA, 2002, 'Rates of combination antiretroviral treatment change in Australia, 1997-2000', HIV Medicine, 3, pp. 28 - 36
2002
Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 162 - 168
2001
Medland N, 2001, 'Sexually transmitted diseases in HIV-1-infected patients', LANCET, 357, pp. 1533 - 1534, http://dx.doi.org/10.1016/S0140-6736(00)04693-6
2001
Reports
Fraser D; Medland N; McManus H; Guy R; Grulich A; Bavinton B, 2023, Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia: Issue #8, May 2023, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/6vf7-k313, https://kirby.unsw.edu.au/sites/default/files/kirby/report/Monitoring-HIV-PrEP-uptake-in-Australia-newsletter_Issue8.pdf
2023
Fraser D; Medland N; McManus H; Guy R; Grulich A; Bavinton B, 2022, Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia. Issue #5, January 2022, UNSW, The Kirby Institute, https://kirby.unsw.edu.au/report/monitoring-hiv-prep-uptake-australia-issue5
2022
Fraser D; Medland N; McManus H; Guy R; Grulich A; Bavinton B, 2022, Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia. Issue #6, May 2022, UNSW, The Kirby Institute, https://kirby.unsw.edu.au/report/monitoring-hiv-prep-uptake-australia-issue6
2022
Fraser D; Medland N; McManus H; Guy R; Grulich A; Bavinton B, 2022, Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia: Issue #7, October 2022, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/zaph-vm57, https://kirby.unsw.edu.au/sites/default/files/kirby/report/Monitoring-HIV-PrEP-uptake-in-Australia-newsletter_Issue7.pdf
2022
Fraser D; Medland N; McManus H; Guy R; Grulich A; Bavinton B, 2021, Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia. Issue #4, June 2021, UNSW, The Kirby Institute, https://kirby.unsw.edu.au/report/monitoring-hiv-prep-uptake-australia-issue4
2021
Preprints
Bhatt S; Bryant M; Lau H; Tee B-K; Eu B; O’Bryan J; Woolley I; Mitchell J; Street A; Dobinson S; Medland N; Lamb J; Mahony A; Tramontana A; Lim L-L; Wade A; Roder C; Mitchell W; Sherman C; Bramwell F; Aboltins C; Wong SH; Giourouki M; Hoy J; McMahon J, 2022, Successful Expanded Clinic Network Collaboration and Patient Tracing for Retention in HIV Care, , http://dx.doi.org/10.21203/rs.3.rs-1927352/v1
2022
Abraham E; Chow EPF; Fairley C; Lee D; Kong FYS; Mao L; Goller J; Medland N; Bavinton B; Sudarto B; Joksic S; Wong J; Phillips T; Ong J, 2022, eSexualHealth: Preferences to Use Technology to Promote Sexual Health Among Men Who Have Sex with Men and Trans and Gender Diverse People, , http://dx.doi.org/10.1101/2022.09.26.22280388
2022
Gray R; Camara H; Khawar L; Grulich A; Guy R; McGregor S; Medland N, 2022, National trends in rates of undiagnosed HIV in key populations in Australia: a retrospective observational analysis from 2008 to 2019, , http://dx.doi.org/10.1101/2022.09.23.22280259
2022
Bao Y; Medland NA; Fairley CK; Wu J; Shang X; Chow EPF; Xu X; Ge Z; Zhuang X; Zhang L, Predicting the Diagnosis of HIV and Sexually Transmitted Infections Among Men Who Have Sex with Men Using Different Machine Learning Approaches, , http://dx.doi.org/10.2139/ssrn.3550064
Conference Abstracts
Fraser D; McManus H; Medland N; Grulich A; Guy R; Bavinton B, 2022, 'Recovery in the uptake of pre-exposure prophylaxis (PrEP) in Australia after COVID-19 restrictions: analysis of national pharmacy dispensing data', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 25, pp. 133 - 133, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000834867400250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Medland N; Fairley C; Wu J; Wu X; Chow E; Xu X; Ge Z; Zhuang X; Zhang L, 2021, 'PREDICTING THE DIAGNOSIS OF HIV AND SEXUALLY TRANSMITTED INFECTIONS AMONG MEN WHO HAVE SEX WITH MEN USING MACHINE LEARNING APPROACHES', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 97, pp. A149 - A149, http://dx.doi.org/10.1136/sextrans-2021-sti.391
2021
Medland N; Guy R; Bavinton B; Keen P; Grulich A; Ellard J; Jin F; Paynter H; McManus H, 2020, 'LARGE DIFFERENCES IN DISCONTINUATION OF PBS-SUBSIDISED PREP IN AUSTRALIA: EVALUATION USING NATIONAL PRESCRIPTION DATA', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 17, pp. XVII - XVII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000598625300026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Medland N; Guy R; Grulich A; Bavinton B; Keen P; Ellard J; Jin F; Paynter H; McManus H, 2020, 'Successful national PrEP scale-up in Australia: Evaluation of uptake, adherence, discontinuation and HIV seroconversion from April 2018 to September 2019 using national dispensing data', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 23, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000551988900091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Harney B; Stoove M; Sacks-Davis R; Van Santen D; Fairley C; Medland N; O'Reilly M; Moore R; Tee B; Sasadeusz J; Iser D; Roney J; Matthews G; Gane E; Prins M; Hellard M; Doyle J, 2019, 'RISK BEHAVIORS FOLLOWING HEPATITIS C TREATMENT AMONG GAY AND BISEXUAL MEN LIVING WITH HIV IN MELBOURNE, AUSTRALIA', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 95, pp. A117 - A117, http://dx.doi.org/10.1136/sextrans-2019-sti.297
2019
Doyle J; van Santen D; Iser D; Sasadeusz J; O'reilly M; Harney B; Roney J; Cutts J; Bowring A; Winter R; Medland N; Fairley C; Moore R; Bk T; Hoy J; Gane E; Matthews G; Prins M; Stoove M; Hellard M, 2019, 'Hepatitis C elimination by enhancing care and treatment among HIV co-infected individuals (the co-EC study): Real world evidence of decreasing HCV incidence and prevalence', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E329 - E329, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30643-7
2019
van Santen D; Hoy J; Agius P; Iser D; O'reilly M; Sasadeusz J; Stoove M; Roney J; Moore R; Bk T; Medland N; Fairley C; Gane E; Matthews G; Prins M; Hellard M; Doyle J, 2019, 'Changes in liver stiffness measurements following DAA treatment among HIV/HCV-coinfected individuals: Does HIV contribute to liver disease after HCV cure?', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E204 - E204, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481700380&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Doyle JS; Bowring AL; Iser DM; Sasadeusz J; Roney J; O'Reilly M; Fairley C; Gane E; Hoy J; Matthews GV; Medland N; Moore R; Prins M; Stoove M; Ban-Kiem T; Hellard ME, 2017, 'Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfection', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S524 - S525, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31450-2
2017
Bowing AL; Doyle JS; Iser DM; Sasadeusz J; Roney J; O'Reilly M; Fairley C; Gane E; Hoy J; Matthews GV; Medland N; Moore R; Prins M; Stoove M; Ban-Kiem T; Hellard ME, 2017, 'High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S269 - S270, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30852-8
2017
Medland NA; Chow EPF; Walker RG; Chen M; Read THR; Fairley CK, 2017, 'Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Conference Papers
Doyle J; Iser D; Sasadeusz J; Roney J; Cutts J; Bowring A; Winter R; O'reilly M; Fairley C; Gane E; Hoy J; Matthews G; Medland N; Moore R; Prins M; Tee B; Stoove M; Hellard M, 2018, 'Hepatitis C treatment success in primary and tertiary care among people with HCV/HIV coinfection', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S314 - S314, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30846-8
2018
Jamil MS; Mcmanus H; Callander D; Prestage G; Ali H; Knight V; Duck T; O'connor CC; Chen M; Mcnulty AM; Keen P; Medland N; Hellard M; Grulich AE; Lewis DA; Kaldor JM; Fairley CK; Donovan B; Guy R, 2017, 'OPTIMISING EXISTING SEXUAL HEALTH CLINICS INCREASES HIV TESTING AMONG GAY AND BISEXUAL MEN AT HIGHER RISK OF INFECTION', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A153 - A153, http://dx.doi.org/10.1136/sextrans-2017-053264.395
2017
Middleton T; Taqi R; Russell J; Roth N; Medland N; Birch C, 2004, 'Transmission of antiretroviral drug resistant HIV strains between 1996 and 2003 in Victoria, Australia, and their subsequent evolution in untreated individuals', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SPAIN, Tenerife, pp. U81 - U81, presented at 13th International HIV Drug Resistance Workshop, SPAIN, Tenerife, 08 June 2004 - 12 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231615600123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2004
Awards
2020: Chapter of Sexual Health Medicine of the Royal Australasian College of Physicians Award for Best PhD Thesis
1996: Morley Medal for the best academic performance in English Literature Honours Degree at University College London
1996: Dean's List Citation, English Literature Honours Degree at University College London
1993: Quaint Modern English Language Prize
1987: Prize for academic excellence in pathology, University of Queensland
Research activities
Clinical epidemiology
Impact of clinical interventions on disease transmission
HIV
Sexually Transmitted Infections